Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
29,596,439
-
Total 13F shares
-
2,302,026
-
Share change
-
+189,681
-
Total reported value
-
$64,978,792
-
Price per share
-
$28.21
-
Number of holders
-
39
-
Value change
-
+$5,330,707
-
Number of buys
-
20
-
Number of sells
-
17
Institutional Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q2 2015
As of 30 Jun 2015,
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,302,026 shares.
The largest 10 holders included
MORGAN STANLEY, NEEDHAM INVESTMENT MANAGEMENT LLC, WELLS FARGO & COMPANY/MN, Advisors Asset Management, Inc., UBS Group AG, LPL Financial LLC, FIRST TRUST ADVISORS LP, CREDIT SUISSE AG/, OPPENHEIMER & CO INC, and AMERICAN INTERNATIONAL GROUP INC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.